Status:
ACTIVE_NOT_RECRUITING
Using Technology to Address Disparities and Promote Healthcare Equity in Type 1 Diabetes Registry
Lead Sponsor:
University of Chicago
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
14-64 years
Phase:
NA
Brief Summary
This study is being done to see if using technology, with the help of a Patient Navigator, can help address disparities, improve outcomes, and promote healthcare equity in type 1 diabetes.
Detailed Description
Patients with T1D require an individualized care plan with ongoing education and support. A recent qualitative study of young adults with T1D and end-stage renal disease revealed that childhood enviro...
Eligibility Criteria
Inclusion
- Males or females age 14 to 64 years
- Clinical diagnosis of type 1 diabetes (T1D)
- Two or more hospitalizations with diabetic ketoacidosis (DKA) within the past 5 years or hemoglobin A1c greater than 10% on two or more laboratory samples in the last 2 years.
- Informed Consent
- Has a CGMS or a prescription for a CGMS as part of their clinical care as part of their clinical care
Exclusion
- Inability or unwillingness to share CGMS data with the study team
Key Trial Info
Start Date :
November 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06899984
Start Date
November 20 2020
End Date
March 1 2027
Last Update
November 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637